These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809 [TBL] [Abstract][Full Text] [Related]
4. 5-HT2C receptor agonists as an innovative approach for psychiatric disorders. Rosenzweig-Lipson S; Dunlop J; Marquis KL Drug News Perspect; 2007 Nov; 20(9):565-71. PubMed ID: 18176661 [TBL] [Abstract][Full Text] [Related]
5. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants. Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications. Dunlop J; Marquis KL; Lim HK; Leung L; Kao J; Cheesman C; Rosenzweig-Lipson S CNS Drug Rev; 2006; 12(3-4):167-77. PubMed ID: 17227285 [TBL] [Abstract][Full Text] [Related]
20. Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. Navailles S; Lagière M; Roumegous A; Polito M; Boujema MB; Cador M; Dunlop J; Chesselet MF; Millan MJ; De Deurwaerdère P Int J Neuropsychopharmacol; 2013 Apr; 16(3):593-606. PubMed ID: 22717119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]